Fusion Pharmaceuticals Secures $105 Million to Combat Drug-Resistant Cancers: A Breakthrough Led by CEO John Valliant 00:10:00

Share On Facebook Share On Twitter

Dr. Valliant is Founder and Chief Executive Officer of Fusion Pharmaceuticals. Dr. Valliant has been instrumental in securing both investment and scientific and medical collaborations with the industrial and academic partners of Fusion.

Recent Videos